Yardley V - Search Results

1

Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.

Parveen S, Khan MO, Austin SE, Croft SL, Yardley V, Rock P, Douglas KT. Parveen S, et al. Among authors: yardley v. J Med Chem. 2005 Dec 15;48(25):8087-97. doi: 10.1021/jm050819t. J Med Chem. 2005. PMID: 16335933

2

In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii.

Yardley V, Khan AA, Martin MB, Slifer TR, Araujo FG, Moreno SN, Docampo R, Croft SL, Oldfield E. Yardley V, et al. Antimicrob Agents Chemother. 2002 Mar;46(3):929-31. doi: 10.1128/AAC.46.3.929-931.2002. Antimicrob Agents Chemother. 2002. PMID: 11850291 Free PMC article.

3

Chemotherapy of leishmaniasis.

Croft SL, Yardley V. Croft SL, et al. Among authors: yardley v. Curr Pharm Des. 2002;8(4):319-42. doi: 10.2174/1381612023396258. Curr Pharm Des. 2002. PMID: 11860369 Review.

4

Drug sensitivity of Leishmania species: some unresolved problems.

Croft SL, Yardley V, Kendrick H. Croft SL, et al. Among authors: yardley v. Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S127-9. doi: 10.1016/s0035-9203(02)90063-5. Trans R Soc Trop Med Hyg. 2002. PMID: 12055825 Review.

5

2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase.

Pez D, Leal I, Zuccotto F, Boussard C, Brun R, Croft SL, Yardley V, Ruiz Perez LM, Gonzalez Pacanowska D, Gilbert IH. Pez D, et al. Among authors: yardley v. Bioorg Med Chem. 2003 Nov 3;11(22):4693-711. doi: 10.1016/j.bmc.2003.08.012. Bioorg Med Chem. 2003. PMID: 14556785

6

Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi.

Magaraci F, Jimenez CJ, Rodrigues C, Rodrigues JC, Braga MV, Yardley V, de Luca-Fradley K, Croft SL, de Souza W, Ruiz-Perez LM, Urbina J, Gonzalez Pacanowska D, Gilbert IH. Magaraci F, et al. Among authors: yardley v. J Med Chem. 2003 Oct 23;46(22):4714-27. doi: 10.1021/jm021114j. J Med Chem. 2003. PMID: 14561091

7

Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.

Larabi M, Yardley V, Loiseau PM, Appel M, Legrand P, Gulik A, Bories C, Croft SL, Barratt G. Larabi M, et al. Among authors: yardley v. Antimicrob Agents Chemother. 2003 Dec;47(12):3774-9. doi: 10.1128/AAC.47.12.3774-3779.2003. Antimicrob Agents Chemother. 2003. PMID: 14638481 Free PMC article.

8

Synthesis and in vitro anti-protozoal activity of a series of benzotropolone derivatives incorporating endocyclic hydrazines.

Ren H, Grady S, Banghart M, Moulthrop JS, Kendrick H, Yardley V, Croft SL, Moyna G. Ren H, et al. Among authors: yardley v. Eur J Med Chem. 2003 Nov-Dec;38(11-12):949-57. doi: 10.1016/j.ejmech.2003.07.004. Eur J Med Chem. 2003. PMID: 14642327

9

Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis.

Nan A, Croft SL, Yardley V, Ghandehari H. Nan A, et al. Among authors: yardley v. J Control Release. 2004 Jan 8;94(1):115-27. doi: 10.1016/j.jconrel.2003.09.012. J Control Release. 2004. PMID: 14684276

10

Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.

Jung M, Lee K, Jung H, Kendrick H, Yardley V, Croft SL. Jung M, et al. Among authors: yardley v. Bioorg Med Chem Lett. 2004 Apr 19;14(8):2001-3. doi: 10.1016/j.bmcl.2003.12.104. Bioorg Med Chem Lett. 2004. PMID: 15050646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters